Sanft T - Search Results

1

Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR⁺/HER2^- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1).

Bardia A, Hurvitz SA, DeMichele A, Clark AS, Zelnak A, Yardley DA, Karuturi M, Sanft T, Blau S, Hart L, Ma C, Rugo HS, Purkayastha D, Moulder S. Bardia A, et al. Among authors: sanft t. Clin Cancer Res. 2021 Aug 1;27(15):4177-4185. doi: 10.1158/1078-0432.CCR-20-2114. Epub 2021 Mar 15. Clin Cancer Res. 2021. PMID: 33722897 Free PMC article. Clinical Trial.

2

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.

Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf MM, DiGiovanna MP, Sanft TB, Pusztai L, Gross CP, Chagpar AB. Mougalian SS, et al. Cancer. 2015 Aug 1;121(15):2544-52. doi: 10.1002/cncr.29348. Epub 2015 Apr 22. Cancer. 2015. PMID: 25902916 Free article.

3

Baglia ML, Lin IH, Cartmel B, Sanft T, Ligibel J, Hershman DL, Harrigan M, Ferrucci LM, Li FY, Irwin ML. Baglia ML, et al. Among authors: sanft t. Cancer. 2019 Jul 1;125(13):2262-2271. doi: 10.1002/cncr.32051. Epub 2019 Mar 6. Cancer. 2019. PMID: 30840336 Free PMC article. Clinical Trial.

4

Weight gain after breast cancer diagnosis: It's complicated….

Cathcart-Rake EJ, Sanft T, Tevaarwerk AJ. Cathcart-Rake EJ, et al. Among authors: sanft t. Cancer. 2022 Sep 1;128(17):3152-3154. doi: 10.1002/cncr.34343. Epub 2022 Jul 1. Cancer. 2022. PMID: 35781699 Free article. No abstract available.

5

Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment.

Onishi N, Bareng TJ, Gibbs J, Li W, Price ER, Joe BN, Kornak J, Esserman LJ, Newitt DC, Hylton NM; I-SPY 2 Imaging Working Group; I-SPY 2 Investigator Network. Onishi N, et al. Radiol Imaging Cancer. 2023 Jul;5(4):e220126. doi: 10.1148/rycan.220126. Radiol Imaging Cancer. 2023. PMID: 37505107 Free PMC article.

6

Improving lifestyle behaviors during chemotherapy for breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) Trial.

Puklin LS, Ferrucci LM, Harrigan M, McGowan C, Zupa M, Cartmel B, Li FY, Ligibel JA, Spiegelman D, Sharifi M, Sanft T, Irwin ML. Puklin LS, et al. Among authors: sanft t. Cancer. 2024 Mar 12. doi: 10.1002/cncr.35280. Online ahead of print. Cancer. 2024. PMID: 38470431

7

Patient preferences regarding incidental genomic findings discovered during tumor profiling.

Yushak ML, Han G, Bouberhan S, Epstein L, DiGiovanna MP, Mougalian SS, Sanft TB, Abu-Khalaf MM, Chung GG, Stein SM, Goldberg SB, Pusztai L, Hofstatter EW. Yushak ML, et al. Cancer. 2016 May 15;122(10):1588-97. doi: 10.1002/cncr.29951. Epub 2016 Mar 11. Cancer. 2016. PMID: 26970385 Free article.

8

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors.

Irwin ML, Cartmel B, Harrigan M, Li F, Sanft T, Shockro L, O'Connor K, Campbell N, Tolaney SM, Mayer EL, Yung R, Freedman RA, Partridge AH, Ligibel JA. Irwin ML, et al. Among authors: sanft t. Cancer. 2017 Apr 1;123(7):1249-1258. doi: 10.1002/cncr.30456. Epub 2016 Nov 28. Cancer. 2017. PMID: 27893938 Free PMC article.

9

Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.

Foldi J, Mougalian S, Silber A, Lannin D, Killelea B, Chagpar A, Horowitz N, Frederick C, Rispoli L, Burrello T, Abu-Khalaf M, Sabbath K, Sanft T, Brandt DS, Hofstatter EW, Hatzis C, DiGiovanna MP, Pusztai L. Foldi J, et al. Among authors: sanft t. Breast Cancer Res Treat. 2018 Jun;169(2):333-340. doi: 10.1007/s10549-017-4653-2. Epub 2018 Feb 2. Breast Cancer Res Treat. 2018. PMID: 29396664 Clinical Trial.

10

Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools.

Foldi J, O'Meara T, Marczyk M, Sanft T, Silber A, Pusztai L. Foldi J, et al. Among authors: sanft t. J Clin Oncol. 2019 Jun 1;37(16):1365-1369. doi: 10.1200/JCO.18.01933. Epub 2019 Apr 3. J Clin Oncol. 2019. PMID: 30943126 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page